Pilot Evaluation of the Empower Neuromodulation System in AUD Patients

Inclusion Criteria: * Is male or female ≥ 21 year of age at Visit 1 * Has a current diagnosis of alcohol use disorder per DSM-5 by clinician assessment * Endorses Criterion 4 in DSM-5 * Has a desire to maintain abstinence or, if not abstinent, a desire to reduce or quit alcohol use * Has a breath alcohol concentration of 0.00% at enrollment * Is able to provide informed consent * Is able to understand spoken and written English * Is capable and willing to follow all study-related procedures Exclusion Criteria: * Has been diagnosed with unstable psychosis, epilepsy, peripheral neuropathy, or nerve damage * Requires acute medical detoxification from alcohol based on a score of 12 or more on the Clinical Institute Withdrawal Assessment of Alcohol Scale (CIWA-AD) * Has implanted electrical and/or neurostimulator device (e.g. pacemaker, defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, sacral stimulator, bone growth stimulator, or cochlear implant) * Has an electrically conductive metal object (e.g. jewelry) that cannot be removed from the palm and will directly contact the gel electrodes of the Empower Neuromodulation System * Will not, for the duration of the participation in the study, have a living situation that provides regular access to an electrical outlet. * Is pregnant, breastfeeding, or unwilling to practice birth control during participation in the study * Has used an investigational drug/device therapy within the past 4 weeks * Is deemed unsuitable for enrollment in the study by the PI